Immunopathogenesis of membranous nephropathy: an update. - Wikidata - awgldk - TriplyDB

Immunopathogenesis of membranous nephropathy: an update.

Immunopathogenesis of membranous nephropathy: an update.

http://www.wikidata.org/entity/Q38203172

about

Membranous Nephropathy Associated With Immunological Disorder-Related Liver Disease: A Retrospective Study of 10 Cases Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy Clinical Features and Outcomes in Patients With Membranous Nephropathy and Crescent Formation.Biomarkers to detect membranous nephropathy in Chinese patients.Membranous nephropathy transplanted in the donor kidney: observations of resolving glomerulopathy in serial allograft biopsies.Immunology of membranous nephropathy: from animal models to humans.Treatment of membranous nephropathy: time for a paradigm shift.Genetic risk variants for membranous nephropathy: extension of and association with other chronic kidney disease aetiologies.Circulating (CD3(-)CD19(+)CD20(-)IgD(-)CD27(high)CD38(high)) Plasmablasts: A Promising Cellular Biomarker for Immune Activity for Anti-PLA2R1 Related Membranous Nephropathy?Identification of a major epitope recognized by PLA2R autoantibodies in primary membranous nephropathy.The clinicopathological features of patients with membranous nephropathy.Phospholipase A2 Receptor-Related Membranous Nephropathy and Mannan-Binding Lectin Deficiency.Phospholipase A2 receptor and sarcoidosis-associated membranous nephropathy.Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy.Circulating CD14CD163CD206 M2 Monocytes Are Increased in Patients with Early Stage of Idiopathic Membranous Nephropathy Clinical value of a serum anti-PLA2R antibody in the diagnosis and monitoring of primary membranous nephropathy in adults

P2860

Q36009282-2605D701-7D87-44A1-A9AE-C2F6438300E9 Q36104805-36004A84-D845-4D20-8A6D-9EE628C29682 Q37328402-183473A8-644E-416A-86B6-8C292C9495E9 Q37708722-7BEAFB7F-D83B-4487-B10F-53CD850D217C Q38262445-C1BE39C1-F97E-4F70-B812-98DD62E93BB3 Q38605469-0C511E30-3DC3-4866-90AB-C827A8E98123 Q39410091-B5FC461F-E3A7-4693-B9D9-51A695836709 Q40687484-0154A585-B16C-44AD-9438-EDE691802267 Q41817501-B37986C9-86FA-475B-8B63-D25DDBD9DF3E Q43123391-AA987EA0-4248-47FA-9065-6FC0CE19EC38 Q49220788-C065D83E-B80C-43BC-BA11-7E6D19F31E23 Q49362025-CE6B6B49-51DD-45C6-9A65-58138942B845 Q53556246-F6B4B6A1-F4FC-4105-BBE9-5AF3445B6462 Q55243742-B5358AD5-B5B0-41D2-9EC9-F7FD71606630 Q56568688-A80A8A24-D343-4C0A-9ABD-A8ADB3F7DE80 Q57071948-499DECAF-E728-4FE4-8461-58C5CA000B43

P2860

Immunopathogenesis of membranous nephropathy: an update.

http://www.wikidata.org/entity/Q38203172

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Immunopathogenesis of membranous nephropathy: an update.

@en

type

label

Immunopathogenesis of membranous nephropathy: an update.

@en

prefLabel

Immunopathogenesis of membranous nephropathy: an update.

@en

P1433

Q38203172-BAD1C310-C25C-482A-8FBC-2EB74BCBB2B2

P1476

Q38203172-FEDBFD16-6E6B-422A-A74D-81A4998C07AD

P2093

Q38203172-2A29E7F0-32E0-4185-9DC7-5939C6F381A7

Q38203172-62B65500-C477-4938-9E8A-461597C11930

P2860

Q38203172-003371C8-AB6F-44D4-8A37-B588FF90C66E

Q38203172-00A6A189-AB5C-43D2-B342-3DC534B3FC6C

Q38203172-05182419-A91C-4F13-9650-D0932D9E8D28

Q38203172-09F037CE-D685-4286-AAA9-F0EE74B31B56

Q38203172-0A77C186-2646-4C89-A2A2-495E3FED466D

Q38203172-13412A48-9270-47B2-9E61-BD4B01640AE0

Q38203172-141F07BB-E326-45DF-B6A4-BB785BA6EAB0

Q38203172-14E86468-C03A-4D6D-A490-F73245DFE549

Q38203172-19160B92-9589-4F4A-833B-92F792BAC930

Q38203172-19685223-D046-4145-9165-7FA29BEF6CB9

P2888

Q38203172-B8069D96-64F0-4556-8C60-6F65D3359632

P304

Q38203172-BD0F60B5-ED63-48A9-AF44-661FCAB12AED

P31

Q38203172-274D83D0-3ACD-4E12-AEF3-1C69B12F42C7

P356

Q38203172-36C5619A-C107-42FC-9839-C915E5FAD6CB

P433

Q38203172-42D59406-5242-47E3-A62F-392EB8E5C788

P478

Q38203172-6E1267A0-6866-4DC3-8348-A7E0310AF0E8

P577

Q38203172-FB93CCCF-9890-4B43-A3E7-BD5421C1C306

P5875

Q38203172-9978D892-33C0-4EF5-8754-40AAD490398A

P6179

Q38203172-0A242D21-BA2D-4F28-8BFF-9D187A0FDD05

P698

Q38203172-B09F99DC-DC81-4534-8BFF-18863B8BCA16

P356

S00281-014-0423-Y

P1433

Seminars in Immunopathology

P1476

Immunopathogenesis of membranous nephropathy: an update.

@en

P2093

Hanna Debiec

http://www.w3.org/2001/XMLSchema#string

Pierre Ronco

http://www.w3.org/2001/XMLSchema#string

P2860

Atypical hemolytic uremic syndrome

The M-type receptor PLA2R regulates senescence through the p53 pathway

M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy

Membrane attack by complement: the assembly and biology of terminal complement complexes

Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study

The mannose receptor family

Extended and bent conformations of the mannose receptor family

A common CFH haplotype, with deletion of CFHR1 and CFHR3, is associated with lower risk of age-related macular degeneration

Cell signals transduced by complement

Receptor-mediated endocytosis of α-galactosidase A in human podocytes in Fabry disease

P2888

s00281-014-0423-y

P304

381-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00281-014-0423-Y

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2014-04-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

261516998

http://www.w3.org/2001/XMLSchema#string

P6179

1047548335

http://www.w3.org/2001/XMLSchema#string

P698

24715030

http://www.w3.org/2001/XMLSchema#string